Document is current
Any future updates will be listed below
-
Authors
Gudmundsdottir, Hallbera
Fogliati, Alessandro
Grotz, Travis E.
Thiels, Cornelius A.
Warner, Susanne G.
Smoot, Rory L.
Truty, Mark J.
Kendrick, Michael L.
Nagorney, David M.
Halfdanarson, Thorvardur R.
Cleary, Sean P.
Starlinger, Patrick
- License Information
-
More Information
Article History
Received: 15 August 2023
Accepted: 1 April 2024
First Online: 30 April 2024
Disclosures
: Thorvardur R. Halfdanarson has undertaken consulting/advisory board work for Ipsen, TerSera, ScioScientific, Curium, Advanced Accelerator Applications (a Novartis company), Terumo, ITM Isotopen Technologien Muenchen, and Crinetics. He has also received research support from Thermo Fisher Scientific, Advanced Accelerator Applications (a Novartis company), Basilea, Turnstone Biologics, and Agios. Hallbera Gudmundsdottir, Alessandro Fogliati, Travis E. Grotz, Cornelius A. Thiels, Susanne G. Warner, Rory L. Smoot, Mark J. Truty, Michael L. Kendrick, David M. Nagorney, Sean P. Cleary, and Patrick Starlinger have no relevant financial disclosures and declare no conflicts of interest.
